首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Diagnosis and Management of Pheochromocytoma in an Academic Hospital 3 Years After Formation of A Pheochromocytoma Interest Group
Institution:1. Division of Endocrinology and Carcinoid and Neuroendocrine Tumor Center,;2. Department of Surgery,;3. Department of Pathology, CedarsSinai Medical Center, Los Angeles, California.;1. Department of Medical Laboratory Sciences, University of Delaware, Newark, Delaware,;2. Diabetes and Metabolic Research Center, Christiana Care Health System, Newark, Delaware,;3. Diabetes and Metabolic Diseases Center, Christiana Care Health System, Wilmington, Delaware,;4. Department of Radiology, Christiana Care Health System, Newark, Delaware, and 5Biostatistics Core Facility, University of Delaware, Newark, Delaware.;5. Biostatistics Core Facility, University of Delaware, Newark, Delaware.
Abstract:ObjectiveTo examine whether establishment of a pheochromocytoma interest group improves diagnosis and management of pheochromocytoma in an academic hospital.MethodsThe medical records of patients who had preoperative or pathologic diagnosis of pheochromocytoma at a large academic hospital from July 2007 to July 2010 were retrieved and pertinent information was gathered. Quality measures for diagnosis and management of pheochromocytoma before and after establishment of a pheochromocytoma interest group, and by group and nongroup physicians, were compared.ResultsBetween 2007 and 2010, 16 patients were confirmed to harbor pheochromocytoma. The rates of overdiagnosis and underdiagnosis were similar before and after establishment of the pheochromocytoma interest group (23%-25% vs 17%, respectively); however, after interest group formation, pheochromocytoma was excluded in 9 patients for whom other physicians recommended adrenalectomy. Compared with nonmembers, members of the pheochromocytoma interest group more frequently performed pheochromocytoma testing before adrenal biopsy or adrenalectomy in patients with adrenal masses (71% vs 13%), including those with suspected malignancy (50% vs 7%). After interest group formation, many more patients were optimally prepared preoperatively and advised on follow-up plan and genetic testing.ConclusionsFormation of a pheochromocytoma interest group significantly enhances the quality of diagnosis and management of pheochromocytoma. The key to the group’s success is its incorporation of members’ formal or informal opinions into the care of patients with suspected pheochromocytoma. This model may be applied to other rare endocrine diseases. (Endocr Pract. 2011;17:356-362)
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号